The next Distinguished Scientist Seminar at the University of South Alabama
College of Medicine will feature Dr. Dean J. Burkin, associate professor of pharmacology at the University of Nevada School of Medicine in Reno, Nev.
The lecture, titled "The Matrix Reloaded: Exploring Integrin and Laminin-Based Therapies for the Muscular Dystrophies," will take place March 7, 2013, at 4 p.m. in the Medical Sciences Building auditorium on USA's main campus.
Burkin, a New Zealand native, received undergraduate degrees in biology and developmental biology from Victoria University of Wellington, New Zealand. He completed his doctorate in biochemistry and genetics at the University of Colorado Health Sciences Center and postdoctoral training at Cambridge University, England. He then joined the University of Illinois to complete postdoctoral research before coming to the University of Nevada School of Medicine in 2003.
Dr. Burkin's research aims to define the signaling pathway(s) initiated by integrins during neuromuscular development.
To learn more about Dr. Burkin's research, click here.
